Armed with CRISPR and a $38M round, eGenesis tackles the Holy Grail of xenotransplantation

Read: Armed with CRISPR and a $38M round, eGenesis tackles the Holy Grail of xenotransplantation (ENDPOINTS, 3/16/17)